Immunization Archives - Page 117 of 120 - MPR


BOOSTRIX (Tetanus and reduced diphtheria toxoid, acellular pertussis vaccine) by GlaxoSmithKline

Boostrix Approved for Adults ≥65 Years

GlaxoSmithKline announced that the FDA has approved Boostrix (tetanus and reduced diphtheria toxoid, acellular pertussis vaccine, adsorbed [Tdap]) for use in adults ≥65 years for active booster immunization against tetanus, diphtheria and pertussis.

MENACTRA (meningococcal polysaccharide diphtheria toxoid conjugate vaccine) by Sanofi Pasteur

Menactra Gains Indication for Immunization of Infants

The FDA has expanded the indication for Menactra (meningococcal [Groups A, C, Y and W-135] polysaccharide diphtheria toxoid conjugate vaccine; Sanofi Pasteur) to include a two-dose schedule for infants and children 9-23 months old.

Zostavax Gains Expanded Indication

Merck announced that Zostavax (varicella zoster vaccine, live, attenuated) has gained an expanded indication for the prevention of herpes zoster (shingles) in individuals 50-59 years of age.